Inspire Medical Systems, Inc.

NYSE:INSP

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

Location

United States

Market Cap

USD 2.34 B

Share Price

USD 79.14

Avg Daily Volume

811,427

Change (1 day)

2.71%

Change (1 year)

-57.84%

Change (YTD)

-57.31%

Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2025: 9.43%

Inspire Medical Systems, Inc. EBITDA Margin is 9.43% for the Trailing 12 Months (TTM) ending June 30, 2025, a -1,352.86% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2024 was -0.75%, a -91.99% change year over year.
Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2023 was -9.39%, a -28.29% change year over year.
Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2022 was -13.10%, a -47.67% change year over year.
Inspire Medical Systems, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending June 30, 2021 was -25.04%, a -62.20% change year over year.